RGH 338
Alternative Names: RGH-338Latest Information Update: 28 Apr 2023
At a glance
- Originator Gedeon Richter
- Class Antipsychotics; Anxiolytics
- Mechanism of Action GABA B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pervasive child development disorders
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for phase-I development in Pervasive-child-development-disorders(In volunteers, In adults) in Hungary (PO, Tablet)
- 09 Mar 2020 Phase-I clinical trials in Pervasive child development disorders (In volunteers, In adults) in Hungary (PO) (NL8930)